Application 215465
- Type
- ANDA
- Sponsor
- KNACK
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LEVETIRACETAM | LEVETIRACETAM | INJECTABLE;INTRAVENOUS | 500MG/5ML (100MG/ML) | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A215465-001 | LEVETIRACETAM | LEVETIRACETAM | 500MG/5ML (100MG/ML) | INJECTABLE / INTRAVENOUS | 2025-12-02 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A215465-001 | LEVETIRACETAM | 500MG/5ML (100MG/ML) | INJECTABLE / INTRAVENOUS | 2025-12-02 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A215465-001 | LEVETIRACETAM | 500MG/5ML (100MG/ML) | INJECTABLE / INTRAVENOUS | 2025-12-02 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A215465-001 | LEVETIRACETAM | 500MG/5ML (100MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2025-12-02 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A215465-001 | LEVETIRACETAM | 500MG/5ML (100MG/ML) | INJECTABLE / INTRAVENOUS | AP | 2025-12-02 | 31067a03dcf5… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A215465-001 | LEVETIRACETAM | 500MG/5ML (100MG/ML) | INJECTABLE / INTRAVENOUS | 2025-12-02 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A215465-001 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A215465-001 | AP | 1 | 31067a03dcf5… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levetiracetam | LEVETIRACETAM INJECTION | Dr.Reddy's Laboratories Inc | 0a9234b7-46b1-8e6c-a992-90f86cfb6e00 | 2021-12-31 | Warnings, Adverse reactions | Levetiracetam |
| Levetiracetam | LEVETIRACETAM | Prinston Pharmaceutical Inc. | d818ef84-9b3e-434b-92d9-910cfa8af7da | 2020-08-01 | Warnings, Adverse reactions | Levetiracetam LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | Dr. Reddy's Laboratories Limited | 1f3c04d9-cccb-06a3-a0f3-f7c9228ee743 | 2018-12-05 | Warnings, Adverse reactions | Levetiracetam LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | Dr. Reddy's Laboratories Limited | ee03507b-cb35-4fe9-ae7b-85ea89f876f0 | 2018-12-05 | Warnings, Adverse reactions | Levetiracetam LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | Exelan Pharmaceuticals, Inc. | 28c0e61e-1af9-410a-9fa9-b71bf99a776b | 2018-11-29 | Warnings, Adverse reactions | Levetiracetam LEVETIRACETAM |
| Levetiracetam | LEVETIRACETAM | Amneal Pharmaceuticals LLC | d7932a2c-a3b7-46df-a306-1f17716160a0 | 2017-11-28 | Warnings, Adverse reactions | Levetiracetam LEVETIRACETAM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.